age_bracket_prob_individual_present_at_mda: [10, 40]
age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 15, 20, 60, 100]
allow_new_coinfection_to_cause_symtoms: true
artemisinin_drug_id: 0
birth_rate: 0.03725
circulation_info:
  circulation_percent: 0.0
  length_of_stay: {mean: 5, sd: 10}
  max_relative_moving_value: 35
  moving_level_distribution:
    Exponential: {scale: 0.17}
    Gamma: {mean: 5, sd: 10}
    distribution: Gamma
  number_of_moving_levels: 100
days_mature_gametocyte_over_five: 6
days_mature_gametocyte_under_five: 4
days_to_clinical_over_five: 6
days_to_clinical_under_five: 4
death_rate_by_age_class: [0.053979329, 0.018935757, 0.006867257, 0.001124347, 0.001136455,
  0.001606066, 0.001953783, 0.001530096, 0.001299153, 0.001068073, 0.000978264, 0.000978264,
  0.0055, 0.0055, 0.0445]
drug_db:
  0:
    EC50: {..0..: 0.75, ..1..: 1.2}
    affecting_loci: [2]
    age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4,
      0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
    half_life: 0.0
    k: 4
    maximum_parasite_killing_rate: 0.999
    mutation_probability: 0.005
    n: 25
    name: artmisinin
    selecting_alleles:
    - [1]
  1:
    EC50: {00...: 0.8, 01...: 0.67, 02...: 0.9, 03...: 0.8, 04...: 1.0, 05...: 0.87,
      06...: 1.1, 07...: 1.0, 10...: 0.75, 11...: 0.6, 12...: 0.85, 13...: 0.75, 14...: 0.95,
      15...: 0.8, 16...: 1.05, 17...: 0.95}
    affecting_loci: [0, 1]
    age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4,
      0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
    half_life: 4.5
    k: 4
    maximum_parasite_killing_rate: 0.99
    mutation_probability: 0.005
    n: 20
    name: lumefantrine
    selecting_alleles:
    - [0]
    - [0, 2, 3, 4, 6, 7]
  2:
    EC50: {00...: 0.62, 01...: 0.85, 02...: 0.5, 03...: 0.775, 04...: 0.62, 05...: 0.85,
      06...: 0.5, 07...: 0.775, 10...: 0.7, 11...: 0.9, 12...: 0.65, 13...: 0.82,
      14...: 0.7, 15...: 0.9, 16...: 0.65, 17...: 0.82}
    affecting_loci: [0, 1]
    age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4,
      0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
    half_life: 9.0
    k: 4
    maximum_parasite_killing_rate: 0.95
    mutation_probability: 0.005
    n: 19
    name: amodiaquine
    selecting_alleles:
    - [1]
    - [0, 1, 3, 4, 5, 7]
  3:
    EC50: {'...0.': 0.58, '...1.': 1.4}
    affecting_loci: [3]
    age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4,
      0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
    half_life: 28.0
    k: 4
    maximum_parasite_killing_rate: 0.9
    mutation_probability: 0.005
    n: 15
    name: piperaquine
    resistant_factor:
    - [1]
    selecting_alleles:
    - [1]
  4:
    EC50: {.0...: 0.45, .1...: 0.45, .2...: 0.45, .3...: 0.45, .4...: 1.1, .5...: 1.1,
      .6...: 1.1, .7...: 1.1}
    affecting_loci: [1]
    age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4,
      0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
    half_life: 21.0
    k: 4
    maximum_parasite_killing_rate: 0.9
    mutation_probability: 0.005
    n: 15
    name: Mefloquine
    selecting_alleles:
    - [4, 5, 6, 7]
  5:
    EC50: {'.....': 1.08}
    affecting_loci: []
    age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4,
      0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
    half_life: 6.5
    k: 4
    maximum_parasite_killing_rate: 0.9
    mutation_probability: 0.0
    n: 15
    name: SP
    selecting_alleles: []
  6:
    EC50: {00...: 0.72, 01...: 0.9, 02...: 0.72, 03...: 0.9, 04...: 0.72, 05...: 0.9,
      06...: 0.72, 07...: 0.9, 10...: 1.19, 11...: 1.35, 12...: 1.19, 13...: 1.35,
      14...: 1.19, 15...: 1.35, 16...: 1.19, 17...: 1.35}
    affecting_loci: [0, 1]
    age_specific_drug_concentration_sd: [0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4,
      0.4, 0.4, 0.4, 0.4, 0.4, 0.4]
    half_life: 10
    k: 4
    maximum_parasite_killing_rate: 0.95
    mutation_probability: 0.005
    n: 19
    name: CQ
    selecting_alleles:
    - [1]
    - [1, 3, 5, 7]
ending_date: 2040/1/1
events:
- info: []
  name: introduce_parasites
- info: []
  name: introduce_parasites_periodically
- info:
  - from_day: 2020/1/1
    p_treatment_for_less_than_5_by_location_to: [0.65]
    p_treatment_for_more_than_5_by_location_to: [0.65]
    to_day: 2020/6/1
    type: LinearTCM
  name: change_treatment_coverage
- info: []
  name: change_treatment_strategy
- info:
  - day: 2020/1/1
    days_to_complete_all_treatments: 14
    fraction_population_targeted: [1.0]
  - day: 2020/2/5
    days_to_complete_all_treatments: 14
    fraction_population_targeted: [1.0]
  name: single_round_MDA
external_population_circulation_information:
  circulation_percent: [0.0, 0.01, 0.01, 0.01, 0.01]
  daily_EIR: [0.01, 0.01, 0.01, 0.01, 0.1]
  length_of_stay: {mean: 5, sd: 10}
  max_relative_moving_value: 35
  moving_level_distribution:
    Exponential: {scale: 0.17}
    Gamma: {mean: 5, sd: 10}
    distribution: Gamma
  number_of_moving_levels: 100
  seasonal_EIR:
    a: [1]
    min_value: 0.1
    period: 360
    phi: [180]
fraction_mosquitoes_interrupted_feeding: 0.0
gametocyte_level_full: 1.0
gametocyte_level_under_artemisinin_action: 1.0
genotype_info:
  loci:
  - alleles:
    - allele_name: K76
      can_mutate_to: [1]
      daily_cost_of_resistance: 0.0
      mutation_level: 0
      short_name: K
      value: 0
    - allele_name: 76T
      can_mutate_to: [0]
      daily_cost_of_resistance: 0.0005
      mutation_level: 1
      short_name: T
      value: 1
    locus_name: pfcrt
    position: 0
  - alleles:
    - allele_name: N86 Y184 one copy of pfmdr1
      can_mutate_to: [1, 2, 4]
      daily_cost_of_resistance: 0.0
      mutation_level: 0
      short_name: NY--
      value: 0
    - allele_name: 86Y Y184 one copy of pfmdr1
      can_mutate_to: [3, 0, 5]
      daily_cost_of_resistance: 0.0005
      mutation_level: 1
      short_name: YY--
      value: 1
    - allele_name: N86 184F one copy of pfmdr1
      can_mutate_to: [3, 0, 6]
      daily_cost_of_resistance: 0.0005
      mutation_level: 1
      short_name: NF--
      value: 2
    - allele_name: 86Y 184F one copy of pfmdr1
      can_mutate_to: [1, 2, 7]
      daily_cost_of_resistance: 0.00099975
      mutation_level: 2
      short_name: YF--
      value: 3
    - allele_name: N86 Y184 2 copies of pfmdr1
      can_mutate_to: [0]
      daily_cost_of_resistance: 0.005
      mutation_level: 1
      short_name: NYNY
      value: 4
    - allele_name: 86Y Y184 2 copies of pfmdr1
      can_mutate_to: [1]
      daily_cost_of_resistance: 0.0055
      mutation_level: 2
      short_name: YYYY
      value: 5
    - allele_name: N86 184F 2 copies of pfmdr1
      can_mutate_to: [2]
      daily_cost_of_resistance: 0.0055
      mutation_level: 2
      short_name: NFNF
      value: 6
    - allele_name: 86Y 184F 2 copies of pfmdr1
      can_mutate_to: [3]
      daily_cost_of_resistance: 0.006
      mutation_level: 3
      short_name: YFYF
      value: 7
    locus_name: pfmdr1
    position: 1
  - alleles:
    - allele_name: C580
      can_mutate_to: [1]
      daily_cost_of_resistance: 0.0
      mutation_level: 0
      short_name: C
      value: 0
    - allele_name: 580Y
      can_mutate_to: [0]
      daily_cost_of_resistance: 0.0005
      mutation_level: 1
      short_name: Y
      value: 1
    locus_name: K13 Propeller
    position: 2
  - alleles:
    - allele_name: Plasmepsin 2-3 one copy
      can_mutate_to: [1]
      daily_cost_of_resistance: 0.0
      mutation_level: 0
      short_name: '1'
      value: 0
    - allele_name: Plasmepsin 2-3 2 copies
      can_mutate_to: [0]
      daily_cost_of_resistance: 0.0005
      mutation_level: 1
      short_name: '2'
      value: 1
    locus_name: Plasmepsin 2-3
    position: 3
  - alleles:
    - allele_name: naive
      can_mutate_to: [1]
      daily_cost_of_resistance: 0.0
      mutation_level: 0
      short_name: x
      value: 0
    - allele_name: mutant
      can_mutate_to: [0]
      daily_cost_of_resistance: 0.0005
      mutation_level: 1
      short_name: X
      value: 1
    locus_name: Hypothetical locus for multiple use
    position: 4
immune_system_information: {age_mature_immunity: 10, b1: 0.00125, b2: 0.0025, duration_for_fully_immune: 60,
  duration_for_naive: 300, factor_effect_age_mature_immunity: 1, immune_effect_on_progression_to_clinical: 4,
  immune_inflation_rate: 0.01, max_clinical_probability: 0.99, mean_initial_condition: 0.1,
  min_clinical_probability: 0.05, sd_initial_condition: 0.1}
inflation_factor: 0.01
initial_age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 25, 35,
  45, 55, 65, 100]
initial_parasite_info:
- location_id: -1
  parasite_info:
  - {parasite_type_id: 64, prevalence: 0.05}
  - {parasite_type_id: 72, prevalence: 0.05}
- location_id: 10
  parasite_info:
  - {parasite_type_id: 15, prevalence: 0.05}
  - {parasite_type_id: 20, prevalence: 0.1}
initial_strategy_id: 3
location_db:
  age_distribution_by_location:
  - [0.0334, 0.03, 0.0329, 0.0324, 0.0332, 0.0314, 0.0316, 0.031, 0.0285, 0.0256,
    0.0298, 0.0212, 0.0321, 0.0228, 0.023, 0.1906, 0.1403, 0.0966, 0.0605, 0.0344,
    0.0387]
  beta_by_location: [0.0538]
  location_info:
  - [0, 0, 0]
  p_treatment_for_less_than_5_by_location: [0.6]
  p_treatment_for_more_than_5_by_location: [0.5]
  population_size_by_location: [40000]
lumefantrine_drug_id: 2
mda_therapy_id: 8
mean_prob_individual_present_at_mda: [0.85, 0.75, 0.85]
min_dosing_days: 1
mortality_when_treatment_fail_by_age_class: [0.04, 0.02, 0.02, 0.02, 0.02, 0.004,
  0.004, 0.004, 0.004, 0.004, 0.004, 0.001, 0.001, 0.001, 0.001]
number_of_age_classes: 15
number_of_tracking_days: 11
p_compliance: 1
p_infection_from_an_infectious_bite: 0.1
p_relapse: 0.01
parasite_density_level: {log_parasite_density_asymptomatic: 3, log_parasite_density_clinical: 4.301,
  log_parasite_density_clinical_from: 3.301, log_parasite_density_clinical_to: 5.301,
  log_parasite_density_cured: -4.699, log_parasite_density_detectable: 1.0, log_parasite_density_from_liver: -2.0,
  log_parasite_density_pyrogenic: 3.398}
relapseRate: 4.4721
relapse_duration: 30
relative_bitting_info:
  biting_level_distribution:
    Exponential: {scale: 0.17}
    Gamma: {mean: 5, sd: 10}
    distribution: Gamma
  max_relative_biting_value: 35
  number_of_biting_levels: 100
relative_infectivity: {blood_meal_volume: 3, ro: 0.00031, sigma: 3.91}
report_frequency: 30
sd_prob_individual_present_at_mda: [0.3, 0.3, 0.3]
seasonal_info:
  a: [1]
  enable: 'false'
  min_value: [0.1]
  period: 365
  phi: [250]
spatial_model:
  Barabasi: {beta_r: 1.65, kappa: 350, r_g_0: 5.8}
  Wesolowski: {alpha: 0.22268982, beta: 0.14319618, gamma: 0.83741484, kappa: 0.01093251}
  name: Wesolowski
start_collect_data_day: 0
start_of_comparison_period: 2020/1/1
starting_date: 2006/1/1
strategy_db:
  0:
    distribution: [0.3, 0.3, 0.3, 0.1]
    name: SP-AQ-CQ-AL-OPP
    therapy_ids: [5, 2, 12, 6]
    type: MFT
  1: {name: AL-SFTStrategy, therapy_id: 6, type: SFT}
  2: {name: ASAQ-SFTStrategy, therapy_id: 7, type: SFT}
  3:
    name: BaseLineStrategy
    peak_after: 12418
    peak_distribution:
    - [0.8, 0.2]
    start_distribution:
    - [0.05, 0.95]
    strategy_ids: [1, 0]
    type: NestedMFTMultiLocation
tf_rate: 0.1
tf_testing_day: 28
tf_window_size: 60
therapy_db:
  0:
    dosing_days: [3]
    drug_id: [0]
  1:
    dosing_days: [3]
    drug_id: [1]
  2:
    dosing_days: [3]
    drug_id: [2]
  3:
    dosing_days: [3]
    drug_id: [3]
  4:
    dosing_days: [3]
    drug_id: [4]
  5:
    dosing_days: [3]
    drug_id: [5]
  6:
    dosing_days: [3]
    drug_id: [0, 1]
  7:
    dosing_days: [3]
    drug_id: [0, 2]
  8:
    dosing_days: [3]
    drug_id: [0, 3]
  9:
    dosing_days: [3]
    drug_id: [0, 4]
  10:
    dosing_days: [3]
    drug_id: [0, 3, 4]
  11:
    dosing_days: [3]
    drug_id: [0, 1, 2]
  12:
    dosing_days: [3]
    drug_id: [6]
update_frequency: 7
using_age_dependent_bitting_level: false
using_free_recombination: true
using_variable_probability_infectious_bites_cause_infection: false
